Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin with reduced food effect. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.

Abstract: Systems and techniques to determine, substantially in real time, an estimated ship date or an estimated delivery date associated with a product are described. A commitment engine may receive, from a computing device, data associated with a product that comprises a built-to-order product. The commitment engine may determine whether the product is eligible for one of direct shipment, international parcel direct, or hard merge shipment. The commitment engine may determine a shipping method for the product, determine the estimated ship date, the estimated delivery date or both, and send a message to the computing device information identifying at least one of the estimated ship date or the estimated delivery date.

Abstract: An oral pharmaceutical composition of isotretinoin with reduced food effect. A process for preparing the oral pharmaceutical composition of the present invention.

Abstract: The present invention relates to a pharmaceutical gastro-retentive solid oral dosage form comprising nilotinib as the active ingredient. The invention is further related to methods of preparing said dosage form.

Abstract: A method (200) and a computer readable medium for implementing a document workflow (16) are provided. The method includes receiving a document file (18) from a device (12) via a device application program interface (API) (24). The device (12) can be connected to a network (14). The document file (18) can include information content (20). The method also includes image-processing the document file (18) via a document-processing API (26) to extract the information content (20) from the document file (18). The method further includes invoking document services (28) via the document-processing API (26) to provide the extracted information content (20) to a service application (22) on the network (14).

Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline pharmaceutical composition with or without food. A process of preparing such pharmaceutical composition is also provided.

Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline, a controlled-release polymer, and one or more pharmaceutically acceptable excipients. The invention further provides a method of treatment of rosacea by administering such pharmaceutical composition. A process of preparing such pharmaceutical composition is also provided.

Abstract: A method and apparatus are provided for using data collected from personal sensors, such as those used to monitor health-related factors, to quantify fitness of human relationships. This is done by correlating the sensor data e.g. heart rate, accelerometer, GPS location, from personal electronic devices of users in a relationship, whether romantic, professional or otherwise, and using this data to represent the activities of the users and to characterize the physiological linkage and the emotional impact of those activities on each other. This data can be statistically analyzed to generate a relationship scorecard. By looking at trends of activities, such as stressful conflicts or pleasurable moments, it enables users to improve the quality of their relationships whether professional or personal or romantic.

Abstract: Embodiments relate to facilitating social interactions. An aspect includes determining that a first communications device is in communicative contact with a second communications device, identifying at least one artifact relating to a user of the first communications device, and searching at least one database for information about a user of the second communications device that is in common with the user of the first communications device with respect to the artifact. Also, results of the searching are provided as a topic of conversation to the first communications device.

Abstract: The present invention relates to a method of imparting crush-resistance to an oral solid dosage form comprising a drug prone to abuse, so as to prevent the unintended and illicit use of the dosage form.

Abstract: The present invention relates to a once daily tablet comprising doxycycline at sub-antibiotic dose and one or more pharmaceutically acceptable excipients, wherein the tablet exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline tablet with or without food. A process of preparing the tablet is also provided.

Abstract: The present invention provides a method to provide inferred intentional data analysis to user (s), using sensory data from IoT devices. The method includes step of acquiring plurality of sensory data from one or more IoT devices present in one or more locations, wherein the sensory data is acquired through a DCU (Data Control Unit). The acquired sensory data is routed through DCU to store and collate in the cloud server. The stored sensory data is analyzed in the cloud server to provide the information based on the analysis of stored sensory data, wherein the obtained information is sent to plurality of smart devices. Furthermore, the user's intention is received through the smart devices and stored in the cloud server. Finally, the user's intention is filtered and processed for decision making in cloud server by using sensory data acquired from chosen set of IoT devices as per user's intention.

Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical composition exhibits a reduced food effect. The invention further provides a method of treatment of rosacea by administering to a person in need thereof the doxycycline pharmaceutical composition with or without food. A process of preparing such pharmaceutical composition is also provided.

Abstract: The present invention relates to a once daily pharmaceutical composition comprising doxycycline, a controlled-release polymer, and one or more pharmaceutically acceptable excipients. The invention further provides a method of treatment of rosacea by administering such pharmaceutical composition. A process of preparing such pharmaceutical composition is also provided.

Abstract: The present invention relates to a low dose pharmaceutical composition comprising 32 mg or 34 mg doxycycline and one or more pharmaceutically acceptable excipients for the treatment of acne, and processes for its preparation.

Abstract: The present invention relates to a low dose pharmaceutical composition comprising 24 mg to 36 mg doxycycline and one or more pharmaceutically acceptable excipients for the treatment of acne and/or rosacea, and processes for its preparation.

Abstract: Embodiments relate to facilitating social interactions. An aspect includes determining that a first communications device is in communicative contact with a second communications device, identifying at least one artifact relating to a user of the first communications device, and searching at least one database for information about a user of the second communications device that is in common with the user of the first communications device with respect to the artifact. Also, results of the searching are provided as a topic of conversation to the first communications device.

Abstract: The present invention relates to a pharmaceutical gastro-retentive solid oral dosage form comprising nilotinib as the active ingredient. The invention is further related to methods of preparing said dosage form.

Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin having enhanced bioavailability. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.

Abstract: The present invention provides an oral pharmaceutical composition of isotretinoin with a reduced dose. The present invention further relates to a process for preparing the oral pharmaceutical composition of the present invention.